Month: March 2020

TORONTO, March 17, 2020 (GLOBE NEWSWIRE) — Allied Properties Real Estate Investment Trust (TSX:AP.UN) announced today that it has entered into an agreement to acquire 375 Water Street in Vancouver. Allied intends to fund the acquisition on a long-term basis with proceeds from the sale of a non-managing undivided 50% interest in two fully stabilized properties in its Montréal portfolio.Widely recognized as one of the best Class I buildings in Vancouver, 375 Water will enhance Allied’s ability to serve knowledge-based organizations. On closing, Allied’s Vancouver portfolio will be comprised of 12 properties with just over 643,000 square feet of GLA. On completion of 400 West Georgia early next year, Allied’s portfolio will grow to 820,000 square feet of GLA, propelling Allied toward its goal of becoming a leading provider of distinctive...

HOUSTON, March 17, 2020 (GLOBE NEWSWIRE) — W&T Offshore, Inc. (NYSE: WTI) today announced that it has reduced its capital expenditure budget for 2020 and that it has added natural gas costless collars to its hedging portfolio. Tracy W. Krohn, W&T’s Chairman and Chief Executive Officer commented, “During our recent earnings conference call, we discussed the significant flexibility we have to adjust our capital spending up or down at any time since we have no long-term rig contract commitments or drilling obligations.  Due to the sudden decline in oil prices caused by supply and demand pressures since that call, we have decided to move forward with reducing our 2020 capex to the range of $15 million to $25 million.  Because of the low decline profile of our conventional asset portfolio in the Gulf of Mexico, the reduction...

Net Revenue Increased 9.4%Net Income Increased 57.4%Announces new partnership with Kohl’sContinues to Execute Strategic Initiatives to Deliver Long-Term Revenue and EBITDA GrowthDODGEVILLE, Wis., March 17, 2020 (GLOBE NEWSWIRE) — Lands’ End, Inc. (NASDAQ: LE) today announced financial results for the 13-week fourth quarter and 52-week fiscal year ended January 31, 2020, compared to the 13-week fourth quarter and 52-week fiscal year ended February 1, 2019.Fourth Quarter Fiscal 2019 Highlights:Net revenue for the fourth quarter increased 9.4% to $549.5 million, compared to $502.3 million in the fourth quarter last year, largely reflecting revenue from the American Airlines launch and eCommerce growth of 7.2%. This was partially offset by 49 fewer Lands’ End Shops at Sears, which resulted in a net revenue decline from Sears operations...

Millicom to present at Citi conferenceLuxembourg, March 17, 2020 – Millicom International Cellular S.A. (“Millicom”) announced today that it will take part in the 2020 Citi Communications Services Conference on March 17 and March 18, 2020.The virtual event will include one-on-one video conferences with investors, as well as a presentation by Millicom’s CEO Mauricio Ramos and CFO Tim Pennington scheduled for Wednesday March 18, 2020, at approximately 2pm CET/1pm UK/9am EST.  Materials related to this event will be available on the company’s website, and key issues to be discussed will include:Status of COVID-19 in the Latam markets in which Millicom operates;The Group’s response and business continuity activities;Current trading and activity levels, which had not been affected through mid-March; andThe Group’s liquidity position and leverage...

GUANGZHOU, China, March 17, 2020 (GLOBE NEWSWIRE) — Puyi Inc. (“Puyi” or the “Company”) (NASDAQ: PUYI), a leading third-party wealth management service provider in China focusing on mass affluent and emerging middle class population, announced the appointment of Dr. Lihong Zhai as its new independent director and new member of its audit committee today. As of today, the board has three independent directors and six directors in total.Prior to joining the Company, Dr. Lihong Zhai has more than 30 years’ experiences in the financial industry, including experiences as the lecture in finance at Southwestern University of Finance and Economics and experiences as the director of a well-known trust and financing research institute. In addition, Dr. Zhai has extensive experiences in corporate management, and he has also held multiple senior...

I forbindelse med de seneste dages markedsbevægelser, der har medført stor usikkerhed om priser og stor volatilitet i markedet er det nødvendigt at udvide satserne for tillæg/fradrag for emissioner og indløsninger i afdelingerne angivet nedenfor:Når der igen vendes tilbage til emissionstillæg og indløsningsfradrag i henhold til prospektet vil der blive givet meddelelse herom.Eventuelle spørgsmål til denne meddelelse kan rettes til adm. Martin Madsen, tlf. 44 55 92 00.Med venlig hilsenNykredit Portefølje Administration A/SMartin Udbye Madsen, adm. direktørVedhæftet filUdvideldelse af spreads

LYON, Frankreich und CAMBRIDGE, Mass., March 17, 2020 (GLOBE NEWSWIRE) — ERYTECH Pharma (Nasdaq und Euronext: ERYP), ein klinisch forschendes biopharmazeutisches Unternehmen, das innovative Therapien entwickelt, indem es Wirkstoffe in roten Blutkörperchen einkapselt, hat heute die Ernennung von Dr. med. Melanie Rolli als Mitglied seines Board of Directors bekannt gegeben. ERYTECH wird die Ernennung auf seiner nächsten Hauptversammlung zur Ratifizierung vorlegen. Dr. Rolli verfügt über mehr als 15 Jahre Erfahrung in der globalen Biotechnologie- und Pharmaindustrie, sowohl in Europa als auch in den USA. Die Ernennung von Dr. Rolli folgt auf den Rücktritt von Allene Diaz, die ihre Vorstandstätigkeit zum 30. September 2019 niedergelegt hat.„Wir freuen uns sehr, Melanie in unserem Board of Directors begrüßen zu dürfen“, so Dr. Jean-Paul...

LIONE, Francia e CAMBRIDGE, Mass., March 17, 2020 (GLOBE NEWSWIRE) — ERYTECH Pharma (Nasdaq & Euronext: ERYP), azienda biofarmaceutica in fase clinica che sviluppa terapie innovative incapsulando sostanze farmacologiche all’interno dei globuli rossi, ha annunciato in data odierna la nomina di Melanie Rolli, M.D., al Consiglio di Amministrazione e l’intenzione di proporre la ratifica della sua nomina in occasione della prossima Assemblea generale degli azionisti di ERYTECH. La Dott.ssa Rolli vanta più di 15 anni di esperienza nel settore biofarmaceutico e delle biotecnologie a livello mondiale, sia in Europa che negli Stati Uniti. La Dott.ssa Rolli è stata nominata in sostituzione di Allene Diaz, dimessasi dalla carica in data 30 settembre 2019.“Siamo molto lieti di dare il benvenuto a Melanie nel nostro Consiglio...